Toripalimab in Combination With Platinum Plus Etoposidein Patients With Extensive-Stage Small Cell Lung Cancer
Clinical trial NCT04012606 · COMPLETED
Trial details
- NCT number
- NCT04012606
- Sponsor
- Shanghai Junshi Bioscience Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-07-23
- Primary completion
- 2023-04-20
- Enrollment
- 442
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.